Wu, Yuchi
Yang, Lihong
Li, Lingli
Wu, Xiuqing
Zhong, Zhicong
He, Zhiren
Ma, Hongyan
Wang, Lixin
Lu, Zhaoyu
Cai, Cun
Zhao, Daixin
Meng, Xiangxin
Qi, Airong
Yang, Aicheng
Su, Guobin
Guo, Xinfeng
Liu, Xusheng
Zou, Chuan
Lin, Qizhan
Funding for this research was provided by:
TCM Research Project of Guangdong Provincial Hospital of Chinese Medicine (YN2015MS25)
MOST/SATCM of the People’ s Republic of China (2013BAI02B04)
State Administration of Traditional Chinese Medicine, P.R. China (201007005)
Article History
Received: 18 September 2017
Accepted: 14 February 2018
First Online: 7 March 2018
Ethics approval and consent to participate
: The study protocol has been approved by the Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine (No. B2016–137-01, date: 10 September 2016). This trial will be performed according to Ethical Principles of World Medical Association Declaration of Helsinki (Version Fortaleza 2013). All subjects will receive appropriate treatment without exacerbation of their suffering. Written informed consent will be obtained from all participants (Additional file InternalRef removed). The patients will be given adequate time to raise questions and to consider whether to participate in the study.
: All authors read and approved the final manuscript.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.